Thomas Madden
Amministratore Delegato presso Acuitas Therapeutics, Inc.
Provenienza dei contatti di primo grado di Thomas Madden
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Acuitas Therapeutics, Inc.
 Acuitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Acuitas Therapeutics is a private biotechnology company based in Vancouver, Canada that specializes in developing delivery systems for nucleic acid therapeutics based on lipid nanoparticles. The Canadian company partners with pharmaceutical and biotechnology companies, academic institutes, and non-governmental organizations to advance nucleic acid therapeutics into clinical trials and the marketplace. Acuitas Therapeutics has agreements in place with several partners to use its proprietary lipid nanotechnology in the development of COVID-19 vaccines, including Pfizer/BioNTech for Comirnaty®. The CEO of the company is Thomas Madden.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Thomas Madden tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Notre Dame | College/University | Undergraduate Degree | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing | |
| National Pku Alliance | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 20 |
Settori
| Health Technology | 15 |
| Consumer Services | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 8 |
| Sales & Marketing | 5 |
| Independent Dir/Board Member | 3 |
| Chairman | 3 |
| Chief Executive Officer | 2 |
Contatti più connessi
| Insiders | |
|---|---|
| Stephen Aselage | 20 |
- Borsa valori
- Insiders
- Thomas Madden
- Connessioni Società
